Publication | Closed Access

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Combinatorial ChemistryMedicinal ChemistryMedicineNatural SciencesPharmacological AgentPharmacotherapyChemistryPharmacologyDrug Discovery